Publications by authors named "J Bertz"

Mental health and HIV risk behavior have been studied with ecological momentary assessment (EMA), but this approach has not been combined with tracking of activity space (where people go and what they encounter there) in people with HIV and their social relations, who may be HIV+ or HIV-. Activity space represents a modifiable risk or protective factor for behavior related to health status and quality of life, in both clinical and nonclinical populations. We conducted an observational study with 286 participants (243 HIV+ and 43 HIV-), roughly matched for socioeconomic status and neighborhood of residence via three waves of snowball sampling.

View Article and Find Full Text PDF

Background And Aims: Opioid use disorder (OUD) and opioid dependence lead to significant morbidity and mortality, yet treatment retention, crucial for the effectiveness of medications like buprenorphine-naloxone, remains unpredictable. Our objective was to determine the predictability of 6-month retention in buprenorphine-naloxone treatment using electronic health record (EHR) data from diverse clinical settings and to identify key predictors.

Design: This retrospective observational study developed and validated machine learning-based clinical risk prediction models using EHR data.

View Article and Find Full Text PDF

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are characterized by cytoplasmic deposition of the nuclear TAR-binding protein 43 (TDP-43). Although cytoplasmic re-localization of TDP-43 is a key event in the pathogenesis of ALS/FTD, the underlying mechanisms remain unknown. Here, we identified a non-canonical interaction between 14-3-3θ and TDP-43, which regulates nuclear-cytoplasmic shuttling.

View Article and Find Full Text PDF
Article Synopsis
  • Buprenorphine-naloxone is an effective treatment for opioid use disorder, but many patients don't stick with it long-term, leading to poor outcomes.* -
  • This study examined a machine learning model's ability to predict whether patients would stay in treatment (retention) or drop out (attrition) using electronic medical records and clinical notes.* -
  • The results showed the model could reasonably predict retention versus attrition, achieving an AUROC of 0.77 with combined data and 0.74 using only structured data from electronic records.*
View Article and Find Full Text PDF

Background: Previous studies have shown that environment and health can influence drug use trajectories and the effects of substance use disorder (SUD) treatments. We hypothesized that trajectories of drug use-related problems, based on changes in DSM-5 symptoms, would vary by type(s) of drugs used, health factors, and neighborhood characteristics.

Methods: We assessed mental and physical health, stress, social instability, neighborhood characteristics (disorderliness and home value), and DSM-5 symptom counts at two study visits, 12 months apart, in a community sample (baseline  = 735) in Baltimore, MD.

View Article and Find Full Text PDF